Kiyohiko Hatake

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 707 citations · Full text

Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins.

Hirohisa Saito, Kiyohiko Hatake, Ann M. Dvořàk et al. · Proceedings of the National Academy of Sciences · 1988 · 324 citations · Full text

Suspension Cultures, Lymphocyte Development, Immunology +18

Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2

Satoshi Takagi, Shigeo Sato, Tomoko Oh‐hara et al. · PLoS ONE · 2013 · 205 citations · Full text

Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7

Norio Komatsu, Masayuki Yamamoto, Hiroki Fujita et al. · Blood · 1993 · 172 citations

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 152 citations · Full text

Lymphoid Neoplasia, End-of-induction Pet Response, Medicine +7